Introduction
The UK is facing a significant obesity crisis, with nearly one in three adults classified as obese[1]. Mounjaro reviews UK
In response, new medications like Mounjaro (generic name tirzepatide) are emerging as game-changing weight loss treatments.
Mounjaro is a weekly injectable medication originally developed for type 2 diabetes. But it has demonstrated remarkable effectiveness in helping patients lose weight.
This comprehensive guide will explore what is, how it works for weight loss. Patient results, side effects, and how to buy Mounjaro safely in the UK.
What is Mounjaro (Tirzepatide)?
Mounjaro is a prescription medication manufactured by Eli Lilly that was initially approved to treat type 2 diabetes.
It’s a GLP-1 receptor agonist, originally made to control blood sugar.
However, Mounjaro has a unique dual-action mechanism: it mimics two natural hormones (GLP-1 and GIP) that regulate appetite and digestion. By activating these pathways, Mounjaro helps suppress appetite and promote a feeling of fullness, leading to reduced food intake. In simpler terms, patients on Mounjaro feel less hungry and get fuller faster, which aids in weight loss.
In clinical use, Mounjaro is given as a once-weekly injection using a pre-filled pen. It is typically started at a low dose and gradually increased under medical supervision. Although originally a diabetes treatment, its powerful weight-loss effects have made it a popular off-label obesity therapy worldwide. In the UK, Mounjaro was introduced in early 2024 for weight management via private clinics due to high demand. It is sometimes referred to as a “twincretin” because it targets two incretin hormones. By tackling multiple metabolic pathways, Mounjaro can achieve greater weight loss than older single-hormone medications.
How Does Mounjaro Work for Weight Loss?
Mounjaro’s weight loss effect comes from its ability to influence the body’s appetite and metabolism hormones. When you inject Mounjaro, it signals your brain that you’re full and slows down how quickly your stomach empties. This leads to eating smaller portions and fewer cravings.
Tirzepatide boosts insulin release and lowers liver sugar production, improving metabolism.
This dual hormone approach (affecting both GLP-1 and GIP receptors) is what sets Mounjaro apart. By targeting two key appetite-regulating hormones instead of just one, Mounjaro can produce more significant weight loss for many patients.
Clinical trials show Mounjaro users lost around 22–23% of their body weight in 72 weeks.
This level of weight loss is unmatched, even outperforming older drugs like semaglutide (Wegovy).
For example, 23% weight loss means a 90 kg patient could lose about 20 kg. Such outcomes approach what is typically seen with bariatric surgery, but achieved with a weekly injection and lifestyle changes instead.
Importance
It’s important to note that Mounjaro is most effective when used alongside a healthy diet and exercise. In trials, participants were advised on nutrition and activity, amplifying the drug’s effects. This medication helps control hunger, making it easier for patients to stick to calorie-reduced diets and healthier habits.
. Many describe it as taking away the constant “food noise” in their brain.
In summary, Mounjaro adjusts hormones that control hunger and blood sugar, leading to significant weight loss for eligible individuals.
Mounjaro Weight Loss Results
The clinical evidence behind Mounjaro’s effectiveness is very encouraging. In multiple large studies (such as the SURMOUNT trials), patients with obesity who took Mounjaro experienced unprecedented weight loss outcomes.
On average, trial participants lost 15% to 23% of their body weight, depending on the dose and whether they had diabetes. Higher doses yielded greater weight loss, with the highest dose group losing about 22.5% of their weight over ~1.5 years.
In comparison, semaglutide typically results in around 15% weight loss, highlighting Mounjaro’s superior efficacy in similar timeframes.
For example, a 100 kg patient (15.7 stone) losing 20% would weigh 80 kg, potentially improving or resolving health issues like type 2 diabetes, high blood pressure, and sleep apnea.
It’s no surprise that NICE, the UK’s National Institute for Health and Care Excellence, was quick to recognize Mounjaro’s benefits. In late 2024, NICE recommended Mounjaro for NHS use in patients with severe obesity (BMI over 35 with a related condition), due to its cost-effectiveness.
Clinical Evidence
Beyond the numbers, early real-world use of Mounjaro in the UK private sector has mirrored the trial successes. Many specialists report patients losing significant weight within the first 3–6 months of therapy. It’s common to see a steady 1–2 pounds per week weight loss on Mounjaro.
and sometimes more in the initial weeks. Of course, individual results vary, and not everyone will achieve 20% loss, but the majority of patients respond well when the medication is combined with lifestyle adjustments.
Weight loss with Mounjaro is sustainable as long as the medication continues and healthy habits are maintained.
By targeting biological drivers of overeating (like hunger hormones), Mounjaro helps patients maintain weight loss more easily than previous diets. In clinical trials, weight loss plateaued and was maintained, rather than quickly rebounding.
Overall, the evidence positions Mounjaro as one of the most effective medical therapies for obesity to date.
Its results have been called “transformative,” offering new hope to patients who’ve struggled with traditional weight loss methods.
Mounjaro Weight Loss Reviews from Real Users
Real-life experiences often provide valuable insights. Weight loss results from patients in the UK and globally have been mostly positive and remarkable. On Drugs.com, Mounjaro has an 8.6/10 rating, with 80% of reviewers reporting positive weight loss effects. This is a very high satisfaction rate for any medication. Many users share stories of significant weight loss and improvements in their quality of life while on Mounjaro.
For example, one 49-year-old patient described Mounjaro as “life-changing.” Starting at 189 lbs, she lost 56 pounds in 6 months on Mounjaro, reaching 133 lbs. She felt better than in her 20s and 30s, with improved blood pressure and blood sugar levels. Importantly, she experienced only mild side effects (a bit of fatigue and headache early on) which subsided after the first few weeks.
Another user shared that they lost over 100 lbs in under a year with the help of Mounjaro, after years of yo-yo dieting. This person went from approximately 455 lbs down to 340 lbs over 10 months, and even dropped from a 62-inch waist to a 52-inch waist size (Mounjaro for Weight Loss (Obesity/Overweight) Reviews – Drugs.com). They reported that their appetite dramatically decreased — at times they even had to remind themselves to eat to get proper nutrition. Such a transformation significantly improved their mobility and confidence.
Common themes in Mounjaro reviews include:
- Rapid initial weight loss: Many users see a notable drop in the first month (e.g. 5–10+ lbs lost), which provides motivation to continue.
- Reduced cravings: People often report that junk food or large portions simply stop appealing to them. One reviewer said, “It’s like the constant chatter about food in my brain went silent.”
- Steady progress: Weight loss continues month after month for many, especially as doses are adjusted upward over time.
- Improvement in health metrics: Patients frequently mention better blood sugar control, lower HbA1c (for those with diabetes or prediabetes), reduced blood pressure, and other health improvements alongside the weight loss.
Of course, not every review is glowing — a small percentage of users (around 5–10%) did not have a good experience or had to stop due to side effects (Mounjaro vs Wegovy Comparison – Drugs.com). (We will cover side effects in the next section.) Overall, however, the user feedback indicates that Mounjaro is helping a great number of people finally succeed in losing weight, even if they have battled obesity for years. Reading these real-world reviews can be reassuring if you’re considering treatment, as they show that the impressive numbers from clinical trials translate into real benefits for everyday people.
Side Effects and Safety of Mounjaro
As with any prescription medication, Mounjaro can cause side effects. The good news is that, for most patients, side effects are manageable and tend to improve over time as the body adjusts. The most common side effects reported with Mounjaro are gastrointestinal. In clinical trials and patient reports, the top complaints were:
- Nausea – feeling sick to your stomach
- Diarrhea
- Reduced appetite (which is part of how it works, but can be noticeable as a side effect)
- Vomiting (occasionally, especially if the dose is increased too quickly)
- Constipation
- Heartburn or indigestion
- Stomach pain or discomfort
Effects
These GI-related side effects typically affected more than 5% of patients, usually at the beginning of treatment, and they usually improve within weeks as the body adjusts.. Not everyone gets them, and those who do often find that symptoms are worst in the first day or two after an injection and then fade. Doctors mitigate side effects by starting with a low dose. For instance, you might begin at 2.5 mg per week and gradually titrate up to higher doses (like 10 mg or 15 mg) over a couple of months. This slow increase allows your body to adapt and can greatly reduce the intensity of nausea or other issues.
Patients’ reports back up this strategy: many say any nausea was mild and went away after the first month or two. One user noted she felt slightly queasy and very cold on the day of her shot initially, but by the third month had no such symptoms. Another mentioned a few episodes of constipation, which were resolved with dietary tweaks (more fiber and water).
Despite the predominantly mild side effect profile, there are some rare but serious risks to be aware of. All GLP-1 related therapies, including Mounjaro, carry a warning about the risk of pancreatitis (inflammation of the pancreas). In very rare cases, they may be linked to certain thyroid tumors (seen in animal studies, though not confirmed in humans). As a precaution, Mounjaro is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Very rarely, severe gastrointestinal reactions can occur (one user review described a case of a paralytic ileus, or temporary intestinal paralysis). These serious events are uncommon, but they underscore why taking Mounjaro should be done under medical supervision.
Patients
Overall, for the vast majority of patients, Mounjaro’s side effects are tolerable and a reasonable trade-off for the significant weight loss benefits. Most people experience just mild digestive upset, if anything, and those issues often can be managed with simple measures (like eating smaller meals, avoiding very greasy foods, and staying hydrated). If side effects are troubling, always inform your healthcare provider; they may adjust your dose or suggest remedies. And if you experience severe pain in your abdomen, persistent vomiting, or signs of an allergic reaction, seek medical attention immediately.
In summary, Mounjaro is considered a safe medication for most appropriate candidates, with a well-understood side effect profile. The key is proper screening (to ensure it’s suitable for you) and careful monitoring throughout your treatment. Our clinic will make sure you are fully informed and supported to minimize risks while on your weight loss journey.
How to Buy Mounjaro in the UK (Getting a Prescription)
Mounjaro is a prescription-only medicine, which means you cannot buy it over the counter in the UK – it must be prescribed by a qualified healthcare provider. If you’re interested in using Mounjaro for weight loss, the first step is to have a medical consultation to determine if it’s suitable for you. Here’s how you can get Mounjaro in the UK through our LiveWell weight loss service:
1. Check if you meet the criteria:
Mounjaro is generally recommended for adults who are overweight or obese. Typically, you should have a BMI of 30 or above to qualify for weight loss treatment. If your BMI is between 27 and 30, you may still be eligible if you have a weight-related health condition (such as type 2 diabetes, high blood pressure, or sleep apnea). These criteria are in line with national guidelines for obesity medications. If you’re unsure of your BMI, you can calculate it by dividing your weight in kilograms by the square of your height in meters, or use an online BMI calculator.
2. Complete an online consultation form:
To start the process, you can fill out our secure online consultation form (internal link) on the LiveWell website. This form will ask about your medical history, current medications, and health status. The information you provide is reviewed by our licensed prescribers. This step is crucial to ensure that Mounjaro is safe for you and that there are no contraindications (for example, certain medical conditions or medications that might interact).
3. Medical review by our prescribers:
Our clinicians will evaluate your consultation responses promptly. They will confirm that you meet the BMI criteria and have no medical reasons that would prevent use of Mounjaro. If you have questions or specific concerns, this is a good time to discuss them. We will reach out to ro arrange a video consultation to verify your weight. We will also contact you for additional details if needed, or in some cases arrange a quick phone call to clarify any information. The process is thorough but also convenient, as it can all be done from home.
4. Prescription and purchase:
If you are approved as a suitable candidate, a prescription for Mounjaro will be issued by our prescriber. You can then officially purchase Mounjaro in the UK through our service. We will direct you to our Mounjaro weight loss pen product page (internal link) where you can select the prescribed dose (e.g., 2.5 mg, 5 mg, etc.) and quantity. LiveWell’s pharmacy will dispense the medication. (The medication comes as pre-filled injection pens for weekly use.) Pricing will depend on the dose; higher doses contain more medication and may cost more per pen. We ensure our prices are competitive with other UK providers, and all costs will be clearly explained before you complete the order.
5. Delivery to your door:
Once your order is confirmed, the Mounjaro pens will be dispatched to you. We offer fast, discreet delivery to most UK addresses, so you can start your treatment without delay. The package is kept refrigerated during transit to ensure the medication remains effective. Upon arrival, you should store Mounjaro in your refrigerator as instructed in the patient leaflet.
6. Ongoing support and follow-up:
Our service doesn’t stop at delivery. We provide ongoing support and follow-up. After you begin the injections, we will check in to see how you are responding. You can easily reach out to us via phone or email if you have any side effect concerns or need advice on diet and exercise – we’re here to help you maximize your results. When it’s time for your next month’s supply or a dosage adjustment, we will arrange repeat prescriptions as appropriate, as long as the treatment continues to be safe and effective for you.
It’s worth noting that while Mounjaro is expected to become available through the NHS for a limited group of patients with severe obesity, most people will not qualify for NHS coverage initially. The NHS rollout (starting in 2025) is prioritizing those with a BMI over 35 and serious weight-related conditions. Everyone else — for example, someone with a BMI of 30–34 without complications — will need to use private services like LiveWell to access the medication. This is similar to how other weight loss injections (like Wegovy) have been introduced in the UK. The advantage of going private is that you won’t be subject to long waiting lists or the strict 2-year usage limit that NHS might impose; you can get started as soon as you are approved, and continue as long as it’s benefiting you under our supervision.
Safety and legitimacy:
When buying Mounjaro in the UK, always use a regulated pharmacy or clinic (such as LiveWell). The popularity of weight loss injections has unfortunately led to some black-market products and scams online. Avoid any website offering Mounjaro without a prescription or at an unreasonably low price. With LiveWell, you have the assurance that you are receiving genuine Mounjaro pens sourced through proper UK channels, and that your treatment is supervised by healthcare professionals. We are fully registered and comply with all UK regulations for online prescribing and pharmacy services.
In summary, to buy Mounjaro in the UK, you’ll go through a straightforward process of an online medical consultation, prescription approval, and home delivery of the medication. Our team at LiveWell will guide you each step of the way. If you’re ready to take the first step, simply fill out our online consultation form to get started – and let us help you embark on a healthier weight loss journey with Mounjaro.
References
- Nearly one in three adults are obese in Britain, the highest rate in Europe (Reuters, Dec 2024).
- Obesity is estimated to cost the NHS about £6.5 billion per year (Reuters, June 2023).</em>
- Mounjaro (tirzepatide) is a GLP-1 analogue that suppresses appetite and promotes fullness, leading to significant weight loss (~23% in trials) (Reuters, Dec 2024).
- <em>Clinical trials found Mounjaro achieved greater weight loss than semaglutide (Wegovy), demonstrating its superior efficacy (Reuters, Dec 2024).&amp;lt;/a>
- Mounjaro has an average rating of 8.6/10 from over 1,200 user ratings on Drugs.com, with 80% of reviewers reporting a positive effect (Drugs.com, user reviews).
- Drugs.com user review: A 49-year-old female lost 56 lbs in 6 months on Mounjaro, improving from 189 lbs to 133 lbs with minimal side effects.
- Drugs.com user review: One patient lost 115 lbs (from 455 to 340 lbs) over ten months on Mounjaro, reducing their waist size from 62 inches to 52 inches.
- Common Mounjaro side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, and stomach pain. These effects occurred in >5% of patients and typically improve within a few weeks (Drugs.com).
- Private UK clinics offer Mounjaro for adults with BMI ≥30, or ≥27 with a weight-related health problem, in line with obesity treatment guidelines (Reuters, June 2024).
- NICE has recommended Mounjaro for NHS use (from 2025) for patients with BMI >35 and at least one weight-related condition, similar to the criteria for Wegovy (Reuters, Dec 2024).





